rupiya.io
⠋Loading sector...
0%
❯ Mapping sector landscape...
Specialty exposure and domestic chronic therapy share remain the main margin moats in Indian pharma.
| Company | M.Cap | Price | P/E | P/B | ROE | ROCE | D/E | Div Yield | 1Y Return |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | — | ₹1,854 | — | — | 14.8% | 17.6% | 0.1 | — | +7.18% |
| Divis Laboratories Ltd | ₹2,50,065 Cr | ₹9,415.65 | 83.9 | 14.9 | 16.5% | 22.0% | 0.0 | 0.3% | +46.29% |
| Apollo Hospitals Enterprise Ltd | — | ₹8,946.15 | — | — | 22.6% | 17.0% | 0.9 | — | +23.01% |
| Zydus Lifesciences Ltd | ₹1,12,459 Cr | ₹1,132 | 23.1 | 4.2 | 21.2% | 21.1% | 0.5 | 0.1% | +25.74% |
| Cipla Ltd | — | ₹1,368 | — | — | 11.8% | 14.7% | 0.0 | — | -5.50% |
| Laurus Labs Ltd | — | ₹1,946.1 | — | — | 18.2% | 17.2% | 0.5 | — | +83.89% |
| Max Healthcare Institute Ltd | ₹1,00,553 Cr | ₹1,037.4 | 67.2 | 9.4 | 14.7% | 14.7% | 0.3 | 0.2% | +0.87% |
| Aurobindo Pharma Ltd | — | ₹1,674.1 | — | — | 9.9% | 12.7% | 0.2 | — | +43.37% |
| Dr Reddys Laboratories Ltd | — | ₹1,145.8 | — | — | 8.8% | 13.3% | 0.2 | — | -3.74% |
| Lupin Ltd | — | ₹2,072 | — | — | 27.0% | 27.0% | 0.3 | — | -4.91% |
| Mankind Pharma Ltd | — | ₹2,257.4 | — | — | 12.7% | 11.0% | 0.4 | — | +1.37% |
| Fortis Healthcare Ltd | — | ₹914 | — | — | 11.3% | 10.0% | 0.4 | — | +0.66% |
| Glenmark Pharmaceuticals Ltd | — | ₹2,425.6 | — | — | 23.6% | 39.8% | 0.1 | — | +20.78% |
| Aster DM Healthcare Ltd | — | ₹777.75 | — | — | 10.7% | 11.4% | 0.5 | — | +28.41% |
| Biocon Ltd | — | ₹396.7 | — | — | 1.4% | 3.6% | 0.5 | — | +5.14% |
| Alkem Laboratories Ltd | — | ₹5,142.55 | — | — | 18.9% | 21.2% | 0.2 | — | -12.3% |
| Abbott India Ltd | — | ₹25,322.1 | — | — | 34.5% | 41.4% | 0.0 | — | -9.85% |
| Anthem Biosciences Ltd | — | ₹947.75 | — | — | 22.3% | 30.4% | 0.0 | — | +50.76% |
| Ipca Laboratories Ltd | — | ₹1,975.35 | — | — | 15.7% | 17.0% | 0.1 | — | +29.25% |
| Gland Pharma Ltd | — | ₹2,972.5 | — | — | 10.5% | 13.5% | 0.0 | — | +74.52% |
| GlaxoSmithKline Pharmaceuticals Ltd | — | ₹2,868.1 | — | — | 45.6% | 61.4% | 0.0 | — | +21.06% |
| Ajanta Pharma Ltd | — | ₹3,490 | — | — | 27.1% | 34.5% | 0.1 | — | +27.81% |
| Global Health Ltd | — | ₹1,456.05 | — | — | 15.2% | 17.4% | 0.3 | — | +21.97% |
| Narayana Hrudayalaya Ltd | — | ₹1,906 | — | — | 20.5% | 15.5% | 1.3 | — | +0.97% |
| Emcure Pharmaceuticals Ltd | — | ₹1,956.6 | — | — | 20.1% | 24.0% | 0.3 | — | +30.52% |
| Wockhardt Ltd | — | ₹2,240 | — | — | 6.1% | 7.6% | 0.5 | — | +61.43% |
| Krishna Institute of Medical Sciences Ltd | ₹30,813 Cr | ₹770.05 | 151.0 | 13.7 | 11.0% | 5.2% | 1.9 | — | +23.63% |
| Neuland Laboratories Ltd | — | ₹23,863.05 | — | — | 21.4% | 22.0% | 0.2 | — | +66.57% |
| Piramal Pharma Ltd | — | — | — | — | -4.0% | -1.4% | 0.7 | — | +34.33% |
| Rubicon Research Ltd | — | ₹1,801.75 | — | — | 27.0% | 21.5% | 0.2 | — | +167.04% |
| Granules India Ltd-$ | — | ₹885.5 | — | — | 13.5% | 14.0% | 0.3 | — | +49.22% |
| Caplin Point Laboratories Ltd | ₹20,870 Cr | ₹2,820.45 | 31.4 | 6.2 | 20.9% | 24.2% | 0.1 | 0.3% | +56.27% |
| Pfizer Ltd | — | ₹4,138.8 | — | — | 17.2% | 22.7% | 0.0 | — | -14.17% |
| Shilpa Medicare Ltd | — | ₹965.4 | — | — | 9.8% | 10.3% | 0.3 | — | +212.12% |
| Eris Lifesciences Ltd | ₹18,528 Cr | ₹1,337 | 28.5 | 4.7 | 19.2% | 12.1% | 0.6 | 1.1% | -10.53% |
| Onesource Specialty Pharma Ltd | — | ₹1,551.7 | — | — | -1.3% | -1.4% | 0.3 | — | -12.76% |
| AstraZeneca Pharma India Ltd | — | ₹6,865 | — | — | 22.8% | 25.0% | 0.1 | — | -16.55% |
| Cohance Lifesciences Ltd | — | ₹439.2 | — | — | 4.0% | 4.1% | 0.1 | — | -3.98% |
| Jubilant Pharmova Ltd | — | ₹1,018.3 | — | — | 6.0% | 4.7% | 0.5 | — | -3.04% |
| Alembic Pharmaceuticals Ltd | — | ₹814.5 | — | — | 12.4% | 11.3% | 0.3 | — | +1.74% |
| Natco Pharma Ltd | — | ₹832.9 | — | — | 16.9% | 15.9% | 0.1 | — | -4.46% |
| Concord Biotech Ltd | — | ₹1,450.3 | — | — | 12.5% | 17.1% | 0.0 | — | +7.26% |
| Marksans Pharma Ltd | — | ₹333.05 | — | — | 15.3% | 16.8% | 0.1 | — | +91.9% |
| Rainbow Children's Medicare Ltd | — | ₹1,463.3 | — | — | 18.1% | 13.8% | 0.5 | — | +16.13% |
| Sudeep Pharma Ltd | — | ₹1,276 | — | — | 25.3% | 23.5% | 0.2 | — | +105.34% |
| Corona Remedies Ltd | ₹13,676 Cr | ₹2,205.8 | 64.5 | 18.3 | 29.5% | 33.3% | 0.2 | 0.5% | +57.25% |
| Park Medi World Ltd | — | — | — | — | 17.7% | 15.5% | 0.2 | — | +87.49% |
| Akums Drugs and Pharmaceuticals Ltd | — | ₹745 | — | — | 8.5% | 14.9% | 0.1 | — | +67.6% |
| Viyash Scientific Ltd | — | — | — | — | 8.4% | 9.6% | 0.2 | — | +31.78% |
| Strides Pharma Science Ltd | — | ₹1,200.2 | — | — | 20.0% | 18.3% | 0.6 | — | +29.54% |
| HealthCare Global Enterprises Ltd | — | ₹705.7 | — | — | 2.0% | 0.9% | 1.3 | — | +5.68% |
| Suven Life Sciences Ltd | — | ₹359.5 | — | — | -81.5% | -79.5% | 0.0 | — | +142.19% |
| Blue Jet Healthcare Ltd | — | ₹581.85 | — | — | 19.9% | 23.5% | 0.0 | — | +16.5% |
| Yatharth Hospital & Trauma Care Services Ltd | — | ₹984.85 | — | — | 10.1% | 10.7% | 0.2 | — | +53.93% |
| Jupiter Life Line Hospitals Ltd | — | — | — | — | 13.4% | 12.1% | 0.4 | — | -78.61% |
| Sanofi Consumer Healthcare India Ltd | — | ₹4,033 | — | — | 88.0% | 76.5% | 0.1 | — | -6.22% |
| Procter & Gamble Health Ltd | — | ₹5,501.2 | — | — | 61.5% | 76.7% | 0.0 | — | +1.75% |
| Medplus Health Services Ltd | — | ₹666.25 | — | — | 11.6% | 12.6% | 0.7 | — | -21.27% |
| Entero Healthcare Solutions Ltd | — | ₹1,804.4 | — | — | 6.9% | 10.5% | 0.4 | — | +46.24% |
| Aarti Pharmalabs Ltd | — | ₹830.9 | — | — | 8.5% | 9.2% | 0.4 | — | +8.36% |
| Bliss GVS Pharma Ltd | — | ₹699.1 | — | — | 12.0% | 15.1% | 0.0 | — | +329.95% |
| Nephrocare Health Services Ltd | — | ₹733.05 | — | — | 9.0% | 8.3% | 0.1 | — | +50.91% |
| Supriya Lifescience Ltd | ₹7,366 Cr | ₹915.25 | 37.2 | 6.2 | 19.1% | 22.2% | 0.0 | 0.1% | +13.32% |
| Senores Pharmaceuticals Ltd | — | ₹1,477.1 | — | — | 13.4% | 15.1% | 0.4 | — | +78.43% |
| Innova Captab Ltd | — | ₹1,184.8 | — | — | 13.7% | 15.0% | 0.3 | — | +61.91% |
| Sun Pharma Advanced Research Company Ltd | — | — | — | — | 279.0% | 164.0% | 0.4 | — | +49.61% |
| Morepen Laboratories Ltd | ₹6,441 Cr | — | 45.9 | 5.3 | 8.0% | 8.3% | 0.2 | 0.2% | +205.96% |
| Jeena Sikho Lifecare Ltd | — | ₹507.5 | — | — | 59.9% | 52.2% | 0.3 | — | -29.21% |
| IOL Chemicals & Pharmaceuticals Ltd | — | — | — | — | 7.9% | 9.7% | 0.1 | — | +180.38% |
| Novartis India Ltd | ₹6,039 Cr | ₹2,446 | 61.8 | 7.4 | 11.6% | 15.6% | 0.0 | — | +82.92% |
| FDC Ltd | — | ₹343 | — | — | 11.8% | 14.7% | 0.0 | — | -14.65% |
| Orchid Pharma Ltd | — | ₹1,029.5 | — | — | 0.8% | 0.6% | 0.3 | — | +29.81% |
| RPG Life Sciences Ltd | — | ₹2,774.15 | — | — | 19.3% | 25.7% | 0.0 | — | +10.0% |
| Gufic Biosciences Ltd | ₹4,265 Cr | ₹429.9 | 58.1 | 6.4 | 10.1% | 12.3% | 0.6 | 0.0% | +39.01% |
| Aarti Drugs Ltd | ₹3,856 Cr | ₹422.5 | 20.2 | 2.5 | 13.4% | 11.2% | 0.4 | 0.5% | +7.29% |
| Unichem Laboratories Ltd | — | ₹544.75 | — | — | 9.8% | 10.4% | 0.2 | — | +34.56% |
| SMS Pharmaceuticals Ltd | — | ₹406.65 | — | — | 14.3% | 13.3% | 0.5 | — | +7.65% |
| Kwality Pharmaceuticals Ltd | — | ₹3,525 | — | — | 22.5% | 24.3% | 0.4 | — | +284.23% |
| Ind-Swift Laboratories Ltd | — | ₹396.15 | — | — | 3.2% | 3.5% | 0.0 | — | +304.06% |
| Zota Health Care LImited | — | ₹1,112.7 | — | — | -16.1% | -9.0% | 0.4 | — | -25.87% |
| Indraprastha Medical Corporation Ltd | — | ₹358.6 | — | — | 27.5% | 29.9% | 0.1 | — | -14.55% |
| Hikal Ltd | ₹2,968 Cr | — | 70.0 | 2.5 | 2.2% | 3.5% | 0.6 | 0.3% | +11.1% |
| Dishman Carbogen Amcis Ltd | ₹2,626 Cr | — | 145.0 | 0.4 | 1.6% | 3.1% | 0.5 | 0.0% | -33.44% |
| Dr Agarwals Eye Hospital Ltd-$ | ₹2,522 Cr | ₹5,293.25 | 33.3 | 7.4 | 25.2% | 14.3% | 0.9 | — | +10.48% |
| Medi Assist Healthcare Services Ltd | — | ₹329.6 | — | — | 13.9% | 14.1% | 0.1 | — | -24.08% |
| Sakar Healthcare Limited | — | ₹1,122 | — | — | 9.8% | 10.8% | 0.2 | — | +230.19% |
| Fredun Pharmaceuticals Ltd | — | ₹1,472.95 | — | — | 15.6% | 21.3% | 0.8 | — | +84.98% |
| Panacea Biotec Ltd | — | ₹396.65 | — | — | -0.8% | -0.8% | 0.0 | — | -6.70% |
| Windlas Biotech Ltd | — | ₹1,147.85 | — | — | 12.2% | 14.8% | 0.1 | — | +45.17% |
| Shukra Pharmaceuticals Ltd | ₹2,345 Cr | — | 68.2 | 25.5 | 28.8% | 30.9% | 0.1 | 0.0% | +286.27% |
| Sai Parenterals Ltd | ₹2,326 Cr | ₹526.55 | 119.1 | 3.5 | 4.8% | —% | 1.0 | — | 0.00% |
| Indoco Remedies Ltd | — | — | — | — | -10.1% | -6.9% | 1.2 | — | +13.15% |
| KMC Speciality Hospitals (India) Ltd | — | — | — | — | 24.9% | 21.8% | 0.4 | — | +101.67% |
| Venus Remedies Ltd | — | ₹1,630.1 | — | — | 16.8% | 21.7% | 0.0 | — | +123.0% |
| Hester Biosciences Ltd | — | ₹2,314 | — | — | 16.9% | 14.5% | 0.5 | — | +40.82% |
| Syncom Formulations India Ltd-$ | — | — | — | — | 20.1% | 23.5% | 0.0 | — | +54.07% |
| NGL Fine Chem Ltd | — | ₹2,779.65 | — | — | 15.7% | 16.0% | 0.4 | — | +86.07% |
| Shalby Ltd | ₹1,617 Cr | — | 41.1 | 1.6 | 2.5% | 6.1% | 0.6 | 0.0% | -17.08% |
| Jagsonpal Pharmaceuticals Ltd | — | — | — | — | 16.7% | 20.0% | 0.0 | — | +30.74% |
| Amrutanjan Health Care Ltd-$ | — | ₹511.55 | — | — | 16.6% | 20.4% | 0.0 | — | -16.35% |
| Fermenta Biotech Ltd | — | ₹488.5 | — | — | 18.2% | 21.9% | 0.3 | — | +74.19% |
| Gujarat Kidney and Super Speciality Ltd | — | — | — | — | 11.1% | 14.5% | 0.1 | — | +69.88% |
| GPT Healthcare Ltd | — | — | — | — | 16.3% | 14.2% | 0.3 | — | +20.15% |
| Sigachi Industries Ltd | — | — | — | — | 5.8% | 6.2% | 0.3 | — | +20.27% |
| Lincoln Pharmaceuticals Ltd | — | ₹642 | — | — | 12.3% | 16.3% | 0.0 | — | +26.88% |
| 3B BlackBio Dx Ltd | — | ₹1,481.25 | — | — | 20.2% | 22.6% | 0.0 | — | +7.12% |
| Themis Medicare Ltd | — | — | — | — | 0.3% | 0.5% | 0.3 | — | +38.6% |
| Kopran Ltd | ₹1,139 Cr | — | 45.6 | 2.2 | 4.9% | 6.7% | 0.3 | 1.3% | +63.09% |
| Bharat Parenterals Ltd | ₹1,087 Cr | ₹1,547.5 | — | 3.4 | -2.5% | -1.9% | 0.5 | 0.1% | +27.45% |
| One Global Service Provider Ltd | — | ₹532.35 | — | — | 65.3% | 65.7% | 0.0 | — | +108.89% |
| Health X Platform Ltd | — | — | — | — | -0.2% | -0.2% | 0.0 | — | -2.56% |
| Shree Ganesh Remedies Ltd | ₹902 Cr | ₹702.55 | 58.3 | 5.5 | 11.5% | 12.9% | 0.2 | — | +11.4% |
| Anuh Pharma Ltd | — | — | — | — | 12.1% | 15.3% | 0.0 | — | +14.57% |
| Wanbury Ltd | — | — | — | — | 64.9% | 18.9% | 1.6 | — | +16.48% |
| Gaudium IVF and Women Health Ltd | — | — | — | — | 24.7% | 29.3% | 0.2 | — | 0.00% |
| Max India Ltd | — | — | — | — | -32.8% | -23.0% | 0.2 | — | -13.05% |
| Anlon Healthcare Ltd | ₹835 Cr | — | 22.8 | 3.1 | 18.7% | 16.0% | 0.2 | — | +13.95% |
| Amanta Healthcare Ltd | — | — | — | — | 9.4% | 5.1% | 1.1 | — | +87.04% |
| Zim Laboratories Ltd | ₹687 Cr | — | 158.2 | 2.3 | 2.2% | 2.3% | 0.4 | — | +75.24% |
| Kilitch Drugs India Ltd | ₹657 Cr | — | 21.9 | 2.3 | 10.6% | 13.4% | 0.3 | 0.0% | +7.93% |
| Valiant Laboratories Ltd | — | — | — | — | -1.1% | 0.3% | 0.2 | — | +67.38% |
| Albert David Ltd-$ | — | ₹854.7 | — | — | -0.4% | 0.1% | 0.1 | — | +16.76% |
| Jenburkt Pharmaceuticals Ltd | — | ₹1,044.45 | — | — | 18.8% | 22.9% | 0.0 | — | -21.73% |
| Haleos Labs Ltd | — | ₹1,497.2 | — | — | 8.8% | 8.4% | 0.5 | — | +16.19% |
| Asarfi Hospital Ltd | ₹426 Cr | — | 24.0 | 4.2 | 19.2% | 15.4% | 0.5 | — | +83.87% |
| Medicamen Biotech Ltd-$ | — | — | — | — | 4.0% | 5.4% | 0.2 | — | -27.84% |
| Astal Laboratories Ltd | — | ₹77 | — | — | 4.4% | 3.1% | 0.2 | — | -1.84% |
| Medico Remedies Ltd | — | — | — | — | 19.0% | 23.8% | 0.3 | — | -13.2% |
| Aarey Drugs & Pharmaceuticals Ltd | — | — | — | — | 2.8% | 3.6% | 0.4 | — | +47.65% |
| Trident Lifeline Ltd | — | — | — | — | 23.4% | 18.3% | 0.7 | — | +3.26% |
| Ambalal Sarabhai Enterprises Ltd | ₹318 Cr | — | 22.4 | 2.0 | 12.4% | 11.7% | 0.4 | 0.0% | +43.92% |
| BDH Industries Ltd | — | — | — | — | 14.8% | 19.2% | 0.0 | — | +118.13% |
| Lyka Labs Ltd | — | — | — | — | -10.2% | -6.0% | 0.5 | — | +2.41% |
| Everest Organics Ltd | ₹289 Cr | — | 55.2 | 3.9 | 7.6% | 9.2% | 0.7 | — | -33.76% |
| Sanjivani Paranteral Ltd | — | — | — | — | 15.5% | 15.3% | 0.3 | — | -16.83% |
| Kerala Ayurveda Ltd | — | — | — | — | -128.6% | -42.0% | 5.8 | — | -55.93% |
| Coral Laboratories Ltd | — | — | — | — | 8.0% | 10.8% | 0.0 | — | -17.78% |
| Lotus Eye Hospital And Institute Ltd | — | — | — | — | 0.1% | -0.1% | 0.3 | — | -4.45% |
| Novelix Pharmaceuticals Ltd | — | — | — | — | 5.5% | 6.7% | 0.1 | — | +212.03% |
| Natural Capsules Ltd | — | — | — | — | -13.9% | -9.6% | 0.9 | — | +8.52% |
| Oxygenta Pharmaceutical Ltd | — | — | — | — | —% | -66.1% | — | — | -37.62% |
| Take Solutions Ltd | — | — | — | — | 42.3% | 35.8% | 0.0 | — | -69.44% |
| Brooks Laboratories Ltd | ₹184 Cr | — | 13.9 | 1.5 | 22.0% | 21.2% | 0.1 | 0.0% | -5.39% |
| Syschem India Ltd | — | ₹31.45 | — | — | 8.9% | 11.5% | 0.0 | — | -31.48% |
| Smruthi Organics Ltd | — | — | — | — | 4.7% | 6.1% | 0.1 | — | +1.70% |
| Bal Pharma Ltd | ₹147 Cr | — | 20.4 | 1.8 | 7.9% | 4.7% | 1.9 | 1.1% | +27.26% |
| Parnax Lab Ltd | — | — | — | — | 13.5% | 12.1% | 0.9 | — | +20.93% |
| Auro Laboratories Ltd | — | — | — | — | 7.9% | 5.2% | 1.4 | — | -9.78% |
| Jeevan Scientific Technology Ltd | — | — | — | — | 1.7% | 2.4% | 0.3 | — | +86.49% |
| Alpa Laboratories Ltd | — | — | — | — | 8.4% | 9.0% | 0.0 | — | -15.05% |
| Lactose India Ltd | — | — | — | — | 9.8% | 9.2% | 1.0 | — | +3.65% |
| BALAXI PHARMACEUTICALS LIMITED | ₹131 Cr | — | 53.8 | 0.5 | 0.6% | 3.1% | 0.2 | 0.0% | -44.95% |
| Panchsheel Organics Ltd | — | ₹112.25 | — | — | 7.9% | 9.9% | 0.0 | — | -21.06% |
| Pharmaids Pharmaceuticals Ltd | — | — | — | — | -21.6% | -25.8% | 0.5 | — | -51.64% |
| Makers Laboratories Ltd | ₹112 Cr | — | 32.7 | 1.5 | 11.1% | 8.3% | 0.1 | — | +23.26% |
| Concord Drugs Ltd | — | — | — | — | 2.6% | 2.7% | 0.3 | — | +163.58% |
| Godavari Drugs Ltd | — | — | — | — | 6.9% | 4.4% | 1.0 | — | -0.96% |
| Veerhealth Care Ltd | — | — | — | — | 2.4% | 4.1% | 0.2 | — | +230.27% |
| Mercury Laboratories Ltd | ₹90 Cr | — | 21.7 | 1.6 | 8.7% | 9.9% | 0.2 | 0.4% | -6.57% |
| Sunil Healthcare Ltd | ₹82 Cr | — | 23.1 | 1.2 | 5.9% | 2.3% | 0.8 | — | +8.92% |
| Phaarmasia Ltd | — | ₹88 | — | — | 113.9% | 95.8% | 0.1 | — | +171.94% |
| Kabra Drugs Ltd | — | — | — | — | 18.3% | 19.2% | 0.0 | — | +123.46% |
| Biofil Chemicals & Pharmaceuticals Ltd | — | — | — | — | 13.8% | 15.6% | 0.1 | — | -0.16% |
| Mangalam Drugs & Organics Ltd | — | — | — | — | -34.9% | -41.4% | 1.0 | — | -26.9% |
| Vivo Bio Tech Ltd | — | — | — | — | -2.0% | 3.3% | 0.7 | — | -50.36% |
| Beta Drugs Limited | — | ₹39.4 | — | — | 18.6% | 13.9% | 0.6 | — | -97.83% |
| NG Industries Ltd-$ | ₹39 Cr | — | 20.2 | 1.2 | 4.8% | 6.4% | 0.1 | 3.0% | -24.09% |
| Sandu Pharmaceuticals Ltd | ₹37 Cr | — | 19.3 | 0.9 | 4.1% | 5.9% | 0.0 | 2.6% | -32.22% |
| Lasa Supergenerics Ltd | — | — | — | — | -51.0% | -69.9% | 0.2 | — | -31.89% |
| ANG Lifesciences India Ltd | — | — | — | — | -18.1% | -21.7% | 1.5 | — | -7.41% |
| Deccan Health Care Ltd | — | — | — | — | 2.3% | 2.9% | 0.0 | — | -39.91% |
| Sharma East India Hospitals & Medical Research Ltd | — | — | — | — | 9.5% | 10.7% | 0.5 | — | +20.13% |
| Gujarat Terce Laboratories Ltd | — | — | — | — | 25.7% | 22.3% | 0.1 | — | -35.68% |
| Tejnaksh Healthcare Ltd | — | — | — | — | 4.5% | 5.6% | 0.0 | — | -39.94% |
| Medico Intercontinental Ltd | ₹25 Cr | — | — | 0.5 | -23.0% | -11.8% | 2.1 | — | -37.5% |
| Ishita Drugs & Industries Ltd | — | — | — | — | 7.0% | 9.3% | 0.0 | — | +3.03% |
| Venmax Drugs and Pharmaceuticals Ltd | — | ₹15.49 | — | — | 3.4% | 2.0% | 0.0 | — | -34.86% |
| Maitri Enterprises Ltd | — | — | — | — | 12.1% | 11.3% | 0.9 | — | +26.91% |
| Colinz Laboratories Ltd | — | — | — | — | 5.2% | 6.8% | 0.0 | — | +19.43% |
| Zenlabs Ethica Ltd | — | — | — | — | -20.5% | -17.9% | 1.3 | — | -20.36% |
| Desh Rakshak Aushdhalaya Ltd | ₹15 Cr | — | 29.6 | 1.2 | 4.8% | 4.1% | 0.2 | — | -30.78% |
| Beryl Drugs Ltd | — | — | — | — | 4.3% | 5.6% | 0.3 | — | +18.89% |
| Vivanza Biosciences Ltd | — | — | — | — | 9.3% | 10.3% | 2.3 | — | -23.43% |
| Decipher Labs Ltd | — | — | — | — | -14.2% | -17.8% | 0.0 | — | -53.25% |
India is the pharmacy of the world, supplying 20% of global generic medicine volume. The sector is bifurcated — domestic formulations offer stable growth (10-12%) with high margins, while US generics face pricing erosion but massive volume opportunity. CDMO (Contract Development and Manufacturing) has emerged as a structural growth driver post-COVID.
Key focus areas: domestic chronic therapy mix, specialty pipeline in US, Biosimilar approvals, and FDA compliance track record. Margins vary widely — specialty players earn 25-30% EBITDA margins vs. commodity generics at 12-18%.
Zero or low debt is common, making the sector defensive. Valuations are elevated at 30-40x PE for quality names.
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.